Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,821 to 1,840 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers: results from the RESILIENT trial. | Oncotarget | 2019 | 31608137 | PubTator, text mining | PubMed |
| DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. | Clin Epigenetics | 2019 | 31601247 | PubTator, text mining | PubMed |
| Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis. | PeerJ | 2019 | 31592165 | PubTator, text mining | PubMed |
| A variant of acute promyelocytic leukemia with t(4;17)(q12;q21) showed two different clinical symptoms. | Hematol Rep | 2019 | 31579135 | PubTator, text mining | PubMed |
| Surveillance of Tumour Development: The Relationship Between Tumour-Associated RNAs and Ribonucleases. | Front Pharmacol | 2019 | 31572192 | PubTator, text mining | PubMed |
| Germline NPM1 mutations lead to altered rRNA 2'-O-methylation and cause dyskeratosis congenita. | Nat Genet | 2019 | 31570891 | PubTator, text mining | PubMed |
| The ATRA-21 gene-expression model predicts retinoid sensitivity in CEBPA double mutant, t(8;21) and inv(16) AML patients. | Blood Cancer J | 2019 | 31570689 | PubTator, text mining | PubMed |
| FOXO1 Confers Maintenance of the Dark Zone Proliferation and Survival Program and Can Be Pharmacologically Targeted in Burkitt Lymphoma. | Cancers (Basel) | 2019 | 31557894 | PubTator, text mining | PubMed |
| Educational Case: Acute Promyelocytic Leukemia With PML-RARA. | Acad Pathol | 2019 | 31555723 | PubTator, text mining | PubMed |
| Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies. | Front Oncol | 2019 | 31555592 | PubTator, text mining | PubMed |
| Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group. | Blood | 2019 | 31554635 | PubTator, text mining | PubMed |
| Towards a Better Understanding of Cohesin Mutations in AML. | Front Oncol | 2019 | 31552185 | PubTator, text mining | PubMed |
| Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia. | Front Oncol | 2019 | 31552175 | PubTator, text mining | PubMed |
| Revisiting NTRKs as an emerging oncogene in hematological malignancies. | Leukemia | 2019 | 31551508 | PubTator, text mining | PubMed |
| Quality of Response in Acute Myeloid Leukemia: The Role of Minimal Residual Disease. | Cancers (Basel) | 2019 | 31548502 | PubTator, text mining | PubMed |
| CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies. | Cancers (Basel) | 2019 | 31547472 | PubTator, text mining | PubMed |
| Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid Neoplasms. | Cancers (Basel) | 2019 | 31540291 | PubTator, text mining | PubMed |
| How Cancer Exploits Ribosomal RNA Biogenesis: A Journey beyond the Boundaries of rRNA Transcription. | Cells | 2019 | 31533350 | PubTator, text mining | PubMed |
| RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction. | Cell Rep | 2019 | 31533028 | PubTator, text mining | PubMed |
| Circulating microRNA profile as a potential biomarker for obstructive sleep apnea diagnosis. | Sci Rep | 2019 | 31530881 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=92